DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Vaughn DJ, Hwang WT, Lal p, Rosen MA, Gallagher M, O'Dwyer pJ. et al.
phase 2 trial of the cyclin-dependent kinase 4/6 inhibitor palbociclib in patients with retinoblastoma protein-expressing germ cell tumors.
Cancer 2015;
121: 1463-8
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.